Consolidated Balance Sheet

Perseus Proteomics Inc. - Filing #7591823

Concept As at
2022-06-30
As at
2022-03-31
Consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,008,091,000 JPY
3,214,852,000 JPY
Accounts receivable - trade
18,418,000 JPY
10,115,000 JPY
Prepaid expenses
12,626,000 JPY
4,866,000 JPY
Supplies
2,228,000 JPY
2,504,000 JPY
Other
23,000 JPY
211,000 JPY
Advance payments to suppliers
13,832,000 JPY
22,172,000 JPY
Current assets
3,067,307,000 JPY
3,290,806,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
0 JPY
0 JPY
Intangible assets
0 JPY
0 JPY
Intangible assets
Investments and other assets
Investments and other assets
9,994,000 JPY
9,724,000 JPY
Non-current assets
9,994,000 JPY
9,724,000 JPY
Assets
3,077,301,000 JPY
3,300,530,000 JPY
Liabilities and net assets
Non-current liabilities
12,500,000 JPY
JPY
Current liabilities
112,902,000 JPY
148,375,000 JPY
Accounts payable - other
92,199,000 JPY
114,569,000 JPY
Accrued expenses
9,718,000 JPY
11,548,000 JPY
Deposits received
2,695,000 JPY
2,585,000 JPY
Liabilities
125,402,000 JPY
148,375,000 JPY
Shareholders' equity
2,951,899,000 JPY
3,152,154,000 JPY
Share capital
1,939,252,000 JPY
1,939,252,000 JPY
Capital surplus
2,225,142,000 JPY
2,225,142,000 JPY
Retained earnings
-1,212,495,000 JPY
-1,012,240,000 JPY
Net assets
2,951,899,000 JPY
3,152,154,000 JPY
Liabilities and net assets
3,077,301,000 JPY
3,300,530,000 JPY
Liabilities
Current liabilities
Income taxes payable
5,885,000 JPY
19,672,000 JPY
Provisions
Provision for bonuses
2,403,000 JPY
JPY
Non-current liabilities
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.